New study from Intuitive Biosciences uses CSA assays to monitor candidate vaccine efficacy in nonhuman primate model for SARS-CoV-2.

“A recombinant protein SARS-CoV-2 candidate vaccine elicits high-titer neutralizing antibodies in macaques.” Gary Baisa, David Rancour, Keith Mansfield, Monika Burns, Lori Martin, Daise Cunha, Jessica Fischer,  Frauke Muecksch, Theodora Hatziioannou, Paul D. Bieniasz, Fritz Schomburg, Kimberly Luke* *corresponding author: kluke@intuitivebio.com Vaccines that generate robust and long-lived protective immunity against SARS-CoV-2 infection are urgently required. We assessed the potential of vaccine candidates based…

Learn more »

Using CSA SARS-CoV-2 Tests in Vaccine Studies

“Investigation of SARS-CoV-2 proteins as a potential vaccine targets and development of companion diagnostics for use in nonhuman primates.” Lindsey Moser1, Keith Mansfield2, Monika Burns2, Lori Martin2, Daise Cunha3, Jessica Fischer3, David Rancour4, Fritz Schomburg4, Kimberly Luke1*. Intuitive Biosciences, Madison…

Learn more »

Setting up in-house serology testing

Many research institutions and CROs outsource their serology screening. This can often be a convenient way to get the results needed without having staff and laboratory space committed to that purpose. However, COVID-19 highlighted the need for local services when…

Learn more »
Search